Ionis Pharmaceuticals Inc (NASDAQ:IONS)

64.72
Delayed Data
As of 4:00pm ET
 -2.42 / -3.60%
Today’s Change
40.91
Today|||52-Week Range
86.58
+19.72%
Year-to-Date

Today’s Trading

Previous close67.14
Today’s open67.63
Day’s range63.80 - 68.74
Volume2,588,017
Average volume (3 months)1,194,969
Market cap$9.5B
Data as of 4:00pm ET, 05/24/2019

Growth & Valuation

Earnings growth (last year)+2,515.50%
Earnings growth (this year)-112.85%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+18.12%
P/E ratio24.0
Price/Sales12.09
Price/Book8.87

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.12+0.07%
MYLMylan NV-0.19-0.99%
SRPTSarepta Therapeutics...+2.59+2.19%
BHCValeant Pharmaceutic...-0.15-0.63%
Data as of 4:02pm ET, 05/24/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$599.7M
Annual profit (last year)$276.9M
Net profit margin46.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
Brett P. Monia
Corporate headquarters
Carlsbad, California

Forecasts